US FDA declines to approve expanded use of Alnylam's heart-disease drug

Explore stories from Atlantic Canada.

- The U.S. Food and Drug Administration has declined to approve the expanded use of Alnylam Pharmaceuticals' drug to treat a rare and fatal heart disease, citing insufficient evidence of clinical meaningfulness, the company said on Monday.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

SaltWire Network /  🏆 45. in CA

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Russian rouble tumbles to over 18-month low vs dollarExplore stories from Atlantic Canada.
Read more »

Futures down as Middle East conflict sparks run for safe-haven assetsExplore stories from Atlantic Canada.
Read more »

Huawei-backed Aito says gets 50,000 orders for M7 car since relaunchExplore stories from Atlantic Canada.
Read more »

China extends Taiwan trade probe, Taipei cries election interferenceExplore stories from Atlantic Canada.
Read more »

Israel-bound cruise ships divert to Cyprus, flights addedExplore stories from Atlantic Canada.
Read more »

Thailand working with other countries for release of hostages taken in IsraelExplore stories from Atlantic Canada.
Read more »